STOP-HAE: A Phase 3 Study of ADX-324 in HAE

Clinical trial NCT06960213 · RECRUITING

Trial details

NCT number: NCT06960213
Sponsor: ADARx Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema HAE Hereditary Angioedema - Type 1 Hereditary Angioedema - Type 2

Start date: 2025-08-28
Primary completion: 2027-06-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.